Key differences between apoC-III regulation and expression in intestine and liver.

Abstract

ApoC-III is a critical cardiovascular risk factor, and humans expressing null mutations in apoC-III are robustly protected from cardiovascular disease. Because of its critical role in elevating plasma lipids and CVD risk, hepatic apoC-III regulation has been studied at length. Considerably less is known about the factors that regulate intestinal apoC-III… (More)
DOI: 10.1016/j.bbrc.2017.07.116

Topics

Cite this paper

@article{West2017KeyDB, title={Key differences between apoC-III regulation and expression in intestine and liver.}, author={Gabrielle West and Cayla Rodia and Diana Li and Zania Johnson and Hongli Dong and Alison B. Kohan}, journal={Biochemical and biophysical research communications}, year={2017}, volume={491 3}, pages={747-753} }